Kessler Foundation’s John DeLuca, PhD, honored with Reitan Clinical Excellence Award from National Academy of Neuropsychology

Prestigious award recognizes leadership and innovation in clinical neuropsychology

2025-11-07

(Press-News.org) East Hanover, NJ – Nov. 7, 2025 – John DeLuca, PhD, of Kessler Foundation received the 2025 Reitan Clinical Excellence Award from the National Academy of Neuropsychology (NAN) at its annual conference today. This honor recognizes individuals who have made significant contributions to the clinical practice of neuropsychology, influencing methods, settings, and training in ways that benefit both the profession and its clients.

Dr. DeLuca is senior vice president of Research and Training at the Foundation and a recognized leader in the field of neuropsychology. His work has shaped clinical approaches to cognitive rehabilitation and advanced the understanding of brain function in populations affected by neurological injury and disease. Through decades of research, mentorship, and advocacy, Dr. DeLuca has helped define best practices in neuropsychological care and training.

“I am honored to receive the Reitan Clinical Excellence Award,” said Dr. DeLuca. “Throughout my career, I’ve been driven by the belief that clinical neuropsychology can transform lives. This recognition reflects the collective efforts of my colleagues, collaborators, and the many individuals who have participated in our research. I’m proud to be part of a field that continues to evolve and improve outcomes for people with neurological conditions.”

The Reitan Clinical Excellence Award is NAN’s newest distinction, established to honor those who demonstrate leadership as teachers, clinicians, and theorists, and who have had a notable impact on clinical practice or training in neuropsychology.

About the National Academy of Neuropsychology (NAN)
NAN is a professional organization dedicated to advancing neuropsychology through research, education, and clinical practice. The Academy supports excellence in the field and promotes the application of neuropsychological principles to improve health and quality of life. For more information, visit www.nanonline.org.

About Kessler Foundation
Kessler Foundation, founded in 1985, is a New Jersey-based nonprofit and global leader in rehabilitation research committed to changing the lives of people with disabilities. By conducting groundbreaking research, Kessler Foundation advances recovery and fosters independence to build a more inclusive and accessible world.

Its team of award-winning scientists develop and test novel interventions to transform care and optimize mobility, cognition, and quality of life for people with traumatic brain injury, spinal cord injury, stroke, multiple sclerosis, autism, and other neurological and developmental disabilities. By analyzing community and workforce participation and developing evidence-based solutions, Kessler Foundation also addresses barriers to inclusion for people with disabilities.

Powered by a dedicated team of over 180 professionals funded by federal and state grants and private philanthropy, Kessler Foundation is redefining what is possible in rehabilitation care and recovery. For more information, visit kesslerfoundation.org.

Press Contact at Kessler Foundation:
Carmen Cusido, ccusido@kesslerfoundation.org

Stay Connected with Kessler Foundation
X | Facebook | LinkedIn | Instagram | YouTube |SoundCloud

END

ELSE PRESS RELEASES FROM THIS DATE:

Discordance in creatinine- and cystatin C–based eGFR and clinical outcomes

2025-11-07

About The Study: In the Chronic Kidney Disease Prognosis Consortium, 11% of outpatient participants and 35% of hospitalized patients had a cystatin C–based estimated glomerular filtration rate (eGFRcys) that was at least 30% lower than their creatinine-based eGFR (eGFRcr). In the outpatient setting, presence of eGFRcys at least 30% lower than eGFRcr was associated with significantly higher rates of all-cause mortality, cardiovascular events, and kidney failure. Corresponding Authors: To contact the corresponding authors, email Morgan E. Grams, ...

Disagreement between two kidney function tests predicts serious health problems

2025-11-07

A mismatch between two common tests for kidney function may indicate a higher risk for kidney failure, heart disease, and death, a new study shows. Health care providers for decades have measured blood levels of the molecule creatinine to track the rate at which kidneys filter waste from muscle breakdown in the bloodstream. According to more recent guidelines, levels of cystatin C, a small protein made by all cells in the body, can also be used to measure kidney function. Since these two tests are influenced by different factors — including some related to disease or aging — using both markers together can provide a better measure of kidney function and risk of organ ...

American College of Cardiology, OpenEvidence to advance AI-enabled, evidence-based cardiovascular care

2025-11-07

The American College of Cardiology (ACC) and OpenEvidence are entering a strategic partnership to accelerate the translation of cardiovascular clinical guidance and research into clinical implementation at the point of care. By combining ACC’s leadership in cardiovascular science and education with OpenEvidence’s advanced generative artificial intelligence (AI) technology, clinicians will have access to the latest relevant and actionable medical evidence to support shared decision-making with their patients. “At the American College of Cardiology, our mission is to transform ...

OHSU researchers develop promising drug for aggressive breast cancer

2025-11-07

A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer — a form of cancer that is notoriously aggressive and lacks effective treatments. In a study published today in the journal Cell Reports Medicine, researchers describe the effect of a molecule known as SU212 to inhibit an enzyme that is critical to cancer progression. The research was conducted in a humanized mouse model. “It’s an important step forward to treat triple-negative breast cancer,” said senior author Sanjay V. Malhotra, Ph.D., co-director of the Center for Experimental ...

Evaluating the potential of a sleep intervention among youth at high-risk for borderline personality disorder

2025-11-07

Identifying ways that we can optimize Borderline Personality Disorder (BPD) treatment and prevention is an important public health priority. One area for further research is the relationship between sleep and BPD. Disrupted sleep is closely linked to key BPD features, and prior research has found a range of sleep problems among people with BPD. The Brain & Behavior Research Foundation (BBRF) will host a free webinar, “Evaluating the Potential of a Sleep Intervention Among Youth at High-Risk for Borderline Personality Disorder” on Tuesday, November 11, 2025, at 2:00 pm ET. In this webinar, Erin A. Kaufman, Ph.D., Assistant Professor in the Department ...

Saturn’s icy moon may host a stable ocean fit for life, study finds

2025-11-07

New findings from NASA’s Cassini mission show that Enceladus, one of Saturn’s moons and a top contender for extra-terrestrial life, is losing heat from both poles – indicating that it has the long-term stability required for life to develop. The findings have been published today (7 November) in Science Advances. A new study led by researchers from Oxford University, Southwest Research Institute and the Planetary Science Institute in Tucson, Arizona has provided the first evidence of significant heat flow at Enceladus’ north pole, overturning previous assumptions that heat loss was confined ...

More children, shorter lifespan? Clear evidence from the Great Finnish Famine

2025-11-07

Scientific theory predicts that having more offspring leads to a shorter life span, including in humans. However, despite some hundred years of research, there is no unequivocal evidence for this link. Researchers from the University of Groningen (the Netherlands), the University of Exeter (UK), and the University of Turku (Finland) have now shown that under harsh conditions, the biological cost of reproduction can indeed shorten women’s lifespans. The results were published in Science Advanceson November 7, 2025. In the 1860s, Finland experienced several harsh winters, resulting in a series of poor harvests and famine. Researcher Euan Young from the ...

Climate intervention techniques could reduce the nutritional value of crops

2025-11-07

A new study in Environmental Research Letters reports that cooling the planet by injecting sulfur dioxide into the stratosphere, a proposed climate intervention technique, could reduce the nutritional value of the world’s crops. Scientists at Rutgers University used global climate and crop models to estimate how stratospheric aerosol intervention (SAI), one type of solar geoengineering, would impact the protein level of the world’s four major food crops: maize, rice, wheat, and soybeans. The ...

Mapping resilient supply solutions for graphite, a critical mineral powering energy storage: Rice experts’ take

2025-11-07

HOUSTON – (Nov. 7, 2025) – Graphite, the primary anode material in lithium-ion batteries, has become central to energy storage technologies and a growing focus of supply chain concerns. Even as graphite demand is rising faster than lithium demand, global production remains highly concentrated and carbon-intensive. A perspective article by Rice University researchers traces graphite’s transformation from an industrial commodity to a critical mineral, outlining emerging solutions that could make graphite production ...

Effects of sodium glucose cotransporter 2 inhibitors by diabetes status and level of albuminuria

2025-11-07

About The Study: Within the studied participants, there were clear absolute benefits of sodium-glucose cotransporter 2 (SGLT2) inhibitors on kidney, hospitalization, and mortality outcomes irrespective of diabetes status and level of urine albumin to creatinine ratio. Corresponding Author: To contact the corresponding author, William G. Herrington, MD, email will.herrington@ndph.ox.ac.uk. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jama.2025.20835) Editor’s Note: Please see the article for additional information, including other authors, author contributions ...

LAST 30 PRESS RELEASES:

Cobalt-induced asymmetric electron distribution boosts photocatalytic hydrogen production efficiency

Ultra-low doping 0.1(PtMnFeCoNi)/TiO2 catalysts: Modulating the electronic states of active metal sites to enhance CO oxidation through high entropy strategy